期刊文献+

脑囊尾蚴病的临床用药观察

A Clinical Study on Drug-resistance of Strains of Brain Cysticercosis
暂未订购
导出
摘要 目的 探讨脑囊尾蚴病耐药的原因 ,治疗方法及疗效。 方法 回顾分析 72 6例病人 ,发现 14 2例有耐药现象 ;对 14 2例耐药者强化治疗后的临床症状、CT表现进行分析。 结果  14 2例耐药者单药治疗半年生物学治愈率几乎为零 ,经强化治疗半年后 ,临床治愈率 76 .1% ,生物学治愈率 91.5 %。 结论 脑囊尾蚴病可采用吡喹酮和阿苯哒唑联合用药取得较好疗效 ,不同密度影组疗效欠佳 ,提高临床治愈率尚待探讨。 Objective To explore the reason, the regimen and curative effect of the patients with brain cysticercosis on drug-resistance. Methods By retrospective analysis, 142 among 726 brain cysticercosis patinets were found to have drug-resistance. Analyse the symptoms and cerebral CT scanning of the 142 patients. Result After treatment by one single drug, 142 patients' crue rate of biology is almost zero. After booster-dose treatment for half a year, the cure rate of biology is 91.5%, of symptom is 76.1%. Conclusion Cysticercus' drug-resistance is unavoidable during the treatment, but by means of booster-dose treatment, a better curative effect can be obtained. The curative effect of the patients whose focuses in cerebral CT have different density is poor. The new regimen remains to be studied for a better curative effect.
出处 《实用预防医学》 CAS 2002年第5期458-459,共2页 Practical Preventive Medicine
关键词 脑囊尾蚴病 治疗 吡喹酮 阿苯哒唑 联合用药 疗效 临床用药观察 Brain cysticercosis Computed tomogram Drug resistance Cure rate
  • 相关文献

参考文献5

二级参考文献21

共引文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部